Van Lanschot Kempen Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.05M | Buy |
15,557
+4,565
| +42% | +$1.78M | 0.06% | 201 |
|
|
2025
Q1 | $4.78M | Buy |
10,992
+402
| +4% | +$175K | 0.05% | 188 |
|
|
2024
Q4 | $3.91M | Sell |
10,590
-88
| -0.8% | -$32.5K | 0.04% | 192 |
|
|
2024
Q3 | $5.55M | Sell |
10,678
-70
| -0.7% | -$36.4K | 0.06% | 162 |
|
|
2024
Q2 | $5.82M | Buy |
10,748
+2,863
| +36% | +$1.55M | 0.07% | 154 |
|
|
2024
Q1 | $4.09M | Buy |
7,885
+926
| +13% | +$480K | 0.05% | 166 |
|
|
2023
Q4 | $3.28M | Buy |
6,959
+1,300
| +23% | +$613K | 0.05% | 164 |
|
|
2023
Q3 | $2.46M | Sell |
5,659
-384
| -6% | -$167K | 0.05% | 156 |
|
|
2023
Q2 | $2.68M | Sell |
6,043
-1,613
| -21% | -$717K | 0.05% | 157 |
|
|
2023
Q1 | $3.52M | Buy |
7,656
+415
| +6% | +$191K | 0.07% | 142 |
|
|
2022
Q4 | $3.71M | Buy |
7,241
+710
| +11% | +$364K | 0.11% | 125 |
|
|
2022
Q3 | $2.97M | Buy |
6,531
+384
| +6% | +$174K | 0.12% | 122 |
|
|
2022
Q2 | $2.97M | Buy |
6,147
+238
| +4% | +$115K | 0.11% | 124 |
|
|
2022
Q1 | $2.9M | Buy |
+5,909
| New | +$2.9M | 0.09% | 126 |
|
|
2020
Q2 | – | Sell |
-297
| Closed | -$67K | – | 173 |
|
|
2020
Q1 | $67K | Hold |
297
| – | – | 0.01% | 169 |
|
|
2019
Q4 | $90K | Sell |
297
-5,286
| -95% | -$1.6M | 0.01% | 178 |
|
|
2019
Q3 | $1.34M | Sell |
5,583
-628
| -10% | -$151K | 0.11% | 115 |
|
|
2019
Q2 | $1.75M | Sell |
6,211
-2,815
| -31% | -$795K | 0.15% | 113 |
|
|
2019
Q1 | $2.59M | Buy |
+9,026
| New | +$2.59M | 0.24% | 96 |
|